ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. NYB Holdings's annualizedNet Income for the quarter that ended in Sep. 2025 was $1.34 Mil.
NYB Holdings's average Total Assets over the quarter that ended in Sep. 2025 was $0.79 Mil. Therefore, NYB Holdings's annualized ROA % for the quarter that ended in Sep. 2025 was 170.32%.
The historical rank and industry rank for NYB Holdings's ROA % or its related term are showing as below:
NYB's ROA % is not ranked *
in the Biotechnology industry.
Industry Median: -32.9 * Ranked among companies with meaningful ROA % only.
NYB Holdings (NAS:NYB) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Sep. 2025) net income data. The Revenue data used here is one times the annual (Sep. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
NYB Holdings ROA % Related Terms
NYB Holdings ROA % Historical Data
* Premium members only.
The historical data trend for NYB Holdings's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NYB Holdings ROA % Chart
NYB Holdings Annual Data
Trend
Sep24
Sep25
ROA %
-1,165.90
170.32
NYB Holdings Semi-Annual Data
Sep24
Sep25
ROA %
-1,165.90
170.32
NYB vs : ROA % Comparison
For the Biotechnology subindustry, NYB Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NYB Holdings ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NYB Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where NYB Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Sep. 2025) net income data.
ROA % is displayed in the 30-year financial page.
NYB Holdings (NYB) has a ROA % of 170.32% as of Sep. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on NYB Holdings and its competitors.
Is NYB Holdings' ROA % too high?
NYB Holdings' current ROA % is 170.32%.
How does NYB Holdings' ROA % compare to ?
NYB Holdings' ROA % of 170.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on NYB Holdings and its competitors. NYB Holdings's current ROA % is 170.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NYB Holdings stock overvalued right now?
NYB Holdings (NYB) has a current ROA % of 170.32%. The current ROA % is 170.32%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For NYB Holdings (NYB), the current ROA % is 170.32% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NYB Holdings Ltd, along with its subsidiaries, is a pre-clinical biopharmaceutical company engaged in the research and development of therapeutics and nutraceuticals derived from biodiversity, including tropical medicinal plants with a history of traditional use. It focuses on discovering and developing natural compounds for applications in oncology and other chronic diseases, and also offers a consumer nutraceutical product line.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NYB has been successfully added to your